Close

Tarsus Pharmaceuticals, Inc. Presents New Saturn-1 Pivotal Trial Data and Titan Real-World Prevalence Study Results at ASCRS 2021

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. TSM
3. ISRG
4. INFY
5. SNV
6. TSLA
7. SPY
8. SMCI
9. PPG
10. JWN


Go back to Tarsus Pharmaceuticals, Inc. Presents New Saturn-1 Pivotal Trial Data and Titan Real-World Prevalence Study Results at ASCRS 2021
(NASDAQ: TARS) Delayed: 32.44 -0.41 (1.25%)
Previous Close $32.85    52 Week High $ 
Open $32.44    52 Week Low $ 
Day High $33.69    P/E N/A 
Day Low $31.72    EPS $ 
Volume 657,455